We are live on ! Find out more
11A

10-15 Associates Portfolio holdings

AUM $516M
1-Year Est. Return 7.62%
This Fund
S&P 500
This Quarter Est. Return
+5.9%
1 Year Est. Return
+7.62%
3 Year Est. Return
+32.98%
5 Year Est. Return
+79.47%
10 Year Est. Return
AUM
$356M
AUM Growth
-$3.25M
Cap. Flow
-$10.1M
Cap. Flow %
-2.85%
Top 10 Hldgs %
38.35%
Holding
118
New
3
Increased
19
Reduced
75
Closed
21

Sector Composition

Rank Sector Weight
1 Financials 16.03%
2 Industrials 15.24%
3 Healthcare 13.07%
4 Energy 11.85%
5 Materials 11.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
1
Verizon
VZ
$208B
$29.3M 8.21%
548,362
-71,058
-11% -$3.55M
JPM icon
2
JPMorgan Chase
JPM
$951B
$16M 4.48%
185,207
-7,023
-4% -$536K
PNC icon
3
PNC Financial Services
PNC
$96.6B
$13.4M 3.77%
114,830
-5,567
-5% -$579K
JNJ icon
4
Johnson & Johnson
JNJ
$646B
$12.4M 3.49%
107,860
+6,738
+7% +$778K
INTC icon
5
Intel
INTC
$473B
$11.7M 3.29%
323,665
+44,079
+16% +$1.58M
WDC icon
6
Western Digital
WDC
$166B
$11.7M 3.29%
228,388
-9,970
-4% -$460K
PG icon
7
Procter & Gamble
PG
$334B
$11M 3.09%
130,802
+1,276
+1% +$109K
GE icon
8
GE Aerospace
GE
$355B
$10.9M 3.07%
72,251
-418
-0.6% -$60.7K
AGU
9
DELISTED
Agrium
AGU
$10.2M 2.86%
101,517
-3,960
-4% -$382K
BA icon
10
Boeing
BA
$166B
$9.98M 2.8%
64,107
-1,939
-3% -$283K
DD
11
DELISTED
Du Pont De Nemours E I
DD
$9.7M 2.72%
132,175
-6,029
-4% -$428K
COP icon
12
ConocoPhillips
COP
$157B
$9.57M 2.69%
190,928
-2,152
-1% -$99.2K
PFE icon
13
Pfizer
PFE
$159B
$9.46M 2.65%
307,011
+20,998
+7% +$641K
AXP icon
14
American Express
AXP
$225B
$9.01M 2.53%
121,581
+6,996
+6% +$484K
GSK icon
15
GSK
GSK
$102B
$8.61M 2.41%
178,775
+9,909
+6% +$489K
CSX icon
16
CSX Corp
CSX
$95B
$7.6M 2.13%
634,512
-18,264
-3% -$205K
SLB icon
17
SLB Ltd
SLB
$85.1B
$7.52M 2.11%
89,604
-2,857
-3% -$234K
TGT icon
18
Target
TGT
$74.1B
$7.14M 2%
98,897
+2,075
+2% +$150K
MAS icon
19
Masco
MAS
$14.4B
$6.93M 1.94%
+219,210
New +$7.03M
RDS.B
20
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$6.68M 1.87%
115,270
+90,745
+370% +$4.97M
MRK icon
21
Merck
MRK
$366B
$6.44M 1.81%
114,662
-26,187
-19% -$1.53M
JCI icon
22
Johnson Controls International
JCI
$84.6B
$6.36M 1.78%
154,451
-3,734
-2% -$163K
OXY icon
23
Occidental Petroleum
OXY
$59.1B
$6.35M 1.78%
89,114
-1,871
-2% -$133K
KKR icon
24
KKR & Co
KKR
$97.6B
$6.29M 1.76%
408,620
+2,616
+0.6% +$39.4K
WPM icon
25
Wheaton Precious Metals
WPM
$69.6B
$5.59M 1.57%
289,302
+918
+0.3% +$19.1K

Similar funds

10-15 Associates's Q4 2016 Portfolio in Review

As of Q4 2016, 10-15 Associates held 118 positions worth $356M, down 0.9% from $360M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

10-15 Associates's Q4 2016 filing shows 3 new, 19 increased, 75 reduced and 21 closed positions. Its largest new stake was Masco: 219,210 shares worth $6.93M. The largest sale was Verizon, an estimated $3.55M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.

  • 10-15 Associates's largest Q4 2016 buy was Masco: 219,210 shares worth $6.93M.
  • 10-15 Associates added most to Royal Dutch Shell PLC ADS Class B in Q4 2016, an estimated $4.97M increase.
  • 10-15 Associates's biggest Q4 2016 reduction was Verizon, cutting an estimated $3.55M.
  • 10-15 Associates fully exited Loews in Q4 2016, selling an estimated $642K.
  • 10-15 Associates's ten largest holdings make up 38% of its $356M portfolio in Q4 2016.
  • 10-15 Associates opened 3 new positions and closed 21 in Q4 2016.
  • 10-15 Associates's portfolio value fell 0.9% quarter-over-quarter to $356M.

Based on 10-15 Associates's 13F filing for Q4 2016, filed 14 Feb 2017.